Guest guest Posted March 1, 2010 Report Share Posted March 1, 2010 Hi all We just got back from our annual appointment with `s neuro at UCSF. His last MRI was last August and there are NO new lesions showing, none enhancing. Coming up to his 5 year anniversary on 4.5mg LDN. The only difference this visit appears to be a slight loss of sensation in his feet. You know when they do the test where they put the vibration prong on a toe and you have to say when the tingling stops. Unfortunately said it stopped way before it did on both feet which is different than previous visits. So now he`ll have another MRI, this time just his spine to see if anything shows up. His neuro (2nd to the top man at UCSF) said quite often small spinal lesions dont show on the MRI anyway. Apart from that is in top form. I did ask him about his opinion on CCSCI given that he was the doctor that was interviewed recently for TV about it. He said that he doesnt want people rushing into a very expensive proceedure until there is proof that it works. He said two people have had very bad results from the surgery. I reminded him that plenty of people have actually DIED after taking Tysabri which is still prescribed! He also says he ONLY prescribes LDN if his patients complain of fatigue which is the only thing they have proof of so far that it helps. He is however very excited about the recent publishing of the trials they did at UCSF that proves it helps with fatigue. I told him it has never helped with any fatigue but there you go! So, really, unless you already know about LDN and specifically ask for it for fatigue, he wont offer it. And as we walked out of the suite, we saw the usual dozen or so people in the waiting room, with their walkers and canes. Still very very frustrating! Bev Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.